PT2044020E - Formas cristalinas de 4-[2-(4-metilfenilsulfanil)- fenil] piperidina com inibi??o de reabsor??o combinada de serotonina e norepinefrina para o tratamento da dor neurop?tica - Google Patents
Formas cristalinas de 4-[2-(4-metilfenilsulfanil)- fenil] piperidina com inibi??o de reabsor??o combinada de serotonina e norepinefrina para o tratamento da dor neurop?tica Download PDFInfo
- Publication number
- PT2044020E PT2044020E PT07764496T PT07764496T PT2044020E PT 2044020 E PT2044020 E PT 2044020E PT 07764496 T PT07764496 T PT 07764496T PT 07764496 T PT07764496 T PT 07764496T PT 2044020 E PT2044020 E PT 2044020E
- Authority
- PT
- Portugal
- Prior art keywords
- methylphenylsulfanyl
- piperidine
- phenyl
- treatment
- neuropathic pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/12—Glutaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80500906P | 2006-06-16 | 2006-06-16 | |
DKPA200600816 | 2006-06-16 | ||
DKPA200700423 | 2007-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2044020E true PT2044020E (pt) | 2011-05-12 |
Family
ID=39722478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT07764496T PT2044020E (pt) | 2006-06-16 | 2007-06-15 | Formas cristalinas de 4-[2-(4-metilfenilsulfanil)- fenil] piperidina com inibi??o de reabsor??o combinada de serotonina e norepinefrina para o tratamento da dor neurop?tica |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2014098017A (ko) |
KR (1) | KR101472595B1 (ko) |
AR (1) | AR061480A1 (ko) |
AT (1) | ATE508115T1 (ko) |
BR (1) | BRPI0712758A2 (ko) |
CA (1) | CA2784304A1 (ko) |
DE (1) | DE602007014372D1 (ko) |
DK (1) | DK2044020T3 (ko) |
MY (1) | MY150698A (ko) |
NZ (1) | NZ572856A (ko) |
PT (1) | PT2044020E (ko) |
RS (1) | RS51687B (ko) |
SI (1) | SI2044020T1 (ko) |
TN (1) | TNSN08461A1 (ko) |
TW (1) | TWI444365B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972931B1 (ko) | 2017-10-19 | 2019-04-26 | 재단법인대구경북과학기술원 | 풍선 타입 피질전도 측정장치 및 이의 제조방법 |
CN116930385B (zh) * | 2023-08-08 | 2024-02-20 | 北京爱思益普生物科技股份有限公司 | 一种高盐浓度制剂中化合物浓度的测定方法 |
CN117305360A (zh) * | 2023-09-15 | 2023-12-29 | 江南大学 | 一种哺乳动物细胞核转染液及其制备方法和在细胞核内递送的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
PL2044020T3 (pl) * | 2006-06-16 | 2011-09-30 | H Lundbeck As | Krystaliczne postaci 4-[2-(4-metylofenylosulfanylo)-fenylo]piperydyny z równoczesnym hamowaniem wychwytu zwrotnego serotoniny i norepinefryny do leczenia bólu neuropatycznego |
-
2007
- 2007-06-15 DE DE602007014372T patent/DE602007014372D1/de active Active
- 2007-06-15 RS RS20110223A patent/RS51687B/en unknown
- 2007-06-15 SI SI200730594T patent/SI2044020T1/sl unknown
- 2007-06-15 NZ NZ572856A patent/NZ572856A/en not_active IP Right Cessation
- 2007-06-15 MY MYPI20084894 patent/MY150698A/en unknown
- 2007-06-15 AR ARP070102640A patent/AR061480A1/es unknown
- 2007-06-15 PT PT07764496T patent/PT2044020E/pt unknown
- 2007-06-15 BR BRPI0712758-8A patent/BRPI0712758A2/pt not_active IP Right Cessation
- 2007-06-15 AT AT07764496T patent/ATE508115T1/de active
- 2007-06-15 CA CA2784304A patent/CA2784304A1/en not_active Abandoned
- 2007-06-15 DK DK07764496.1T patent/DK2044020T3/da active
- 2007-06-20 TW TW096121999A patent/TWI444365B/zh not_active IP Right Cessation
-
2008
- 2008-11-17 TN TNP2008000461A patent/TNSN08461A1/en unknown
- 2008-12-11 KR KR1020087030260A patent/KR101472595B1/ko not_active IP Right Cessation
-
2014
- 2014-02-03 JP JP2014018411A patent/JP2014098017A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MY150698A (en) | 2014-02-28 |
TNSN08461A1 (en) | 2010-04-14 |
KR20090018630A (ko) | 2009-02-20 |
SI2044020T1 (sl) | 2011-06-30 |
DK2044020T3 (da) | 2011-08-15 |
AR061480A1 (es) | 2008-08-27 |
TW200817329A (en) | 2008-04-16 |
DE602007014372D1 (de) | 2011-06-16 |
TWI444365B (zh) | 2014-07-11 |
NZ572856A (en) | 2012-02-24 |
RS51687B (en) | 2011-10-31 |
BRPI0712758A2 (pt) | 2012-09-25 |
JP2014098017A (ja) | 2014-05-29 |
CA2784304A1 (en) | 2007-12-21 |
KR101472595B1 (ko) | 2014-12-15 |
ATE508115T1 (de) | 2011-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1134287A1 (en) | Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
IL197420A0 (en) | Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1- | |
HK1142007A1 (en) | 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression | |
IL192241A0 (en) | Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof | |
IL195273A0 (en) | Pharmaceutical use of substituted piperidine carboxamides | |
NO343929B3 (no) | 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte | |
EP2358691B8 (en) | Process for the preparation of piperazine compounds and hydrochloride salts thereof | |
ZA200804198B (en) | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides | |
ZA201103495B (en) | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | |
EP2024323A4 (en) | SALTS OF TRIMEBUTIN AND N-DESMETHYLTRIMEBUTIN | |
GB0612508D0 (en) | Crystalline duloxetine hydrochloride | |
PT2044020E (pt) | Formas cristalinas de 4-[2-(4-metilfenilsulfanil)- fenil] piperidina com inibi??o de reabsor??o combinada de serotonina e norepinefrina para o tratamento da dor neurop?tica | |
GB0700830D0 (en) | Crystalline duloxetine hydrochloride | |
GB0612506D0 (en) | Crystalline duloxetine hydrochloride | |
EP2114150A4 (en) | COMBINATIONS OF BLOCKING OF DOPAMINERGIC D2 RECEPTORS WITH INHIBITION OF NOREPINEPHRINE RECAPTATION AND BLOCKING OF NOREPINEPHRINE ALPHA RECEPTORS | |
HK1140949A1 (en) | Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl) phenyl]piperidine 4-[2-(4-)-] | |
ZA200809917B (en) | Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
ZA200801703B (en) | 3-(2-(Dimethylamino)methyl(cyclohex-1-yl))phenol maleate and its crystalline forms | |
IL198999A0 (en) | Compounds with a combination of cannabinobi-cb1 antagonism and serotonin reuptake inhibition |